DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 158 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $197,741 | +6.4% | 13,388 | -7.0% | 0.07% | +10.0% |
| Q2 2023 | $185,893 | -9.7% | 14,388 | -31.4% | 0.06% | -63.0% |
| Q1 2023 | $205,892 | +21.0% | 20,988 | +31.3% | 0.16% | +45.9% |
| Q4 2022 | $170,112 | -11.9% | 15,988 | -13.5% | 0.11% | -2.6% |
| Q3 2022 | $193,000 | -4.5% | 18,488 | +15.5% | 0.11% | -38.7% |
| Q2 2022 | $202,000 | +14.1% | 16,009 | -1.8% | 0.19% | +27.4% |
| Q1 2022 | $177,000 | +78.8% | 16,300 | +63.0% | 0.15% | +403.4% |
| Q2 2021 | $99,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |